Carfilzomib versus Rituximab for Treatment of De Novo Donor Specific Antibodies in Lung Transplant Recipients

被引：0
|
作者：
Razia, D. [1 ]
Hu, C. [2 ]
Cherrier, L. [3 ]
Nasar, A. [3 ]
Walia, R. [1 ]
Tokman, S. [1 ]
机构：
[1] St Josephs Hosp, Norton Thorac Inst, Phoenix, AZ USA
[2] Univ Arizona, Tucson, AZ USA
[3] St Josephs Hosp, Phoenix, AZ USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2022年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
241
引用
收藏
页码：S112 / S113
页数：2
相关论文
共 50 条
  • [1] Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients
    Razia, Deepika
    Hu, Chengcheng
    Cherrier, Lauren
    Nasar, Aasya
    Walia, Rajat
    Tokman, Sofya
    TRANSPLANT IMMUNOLOGY, 2022, 75
  • [2] Incidence of De Novo Donor Specific Antibodies in Kidney Transplant Recipients
    Staino, C.
    Pilch, N.
    Moussa, O.
    Boyle, K.
    Casale, J.
    Covert, K.
    Fleming, J.
    Taber, D.
    Meadows, H.
    Mardis, C.
    Chavin, K.
    Nadig, S.
    McGillicuddy, J.
    Bratton, C.
    Srinivas, T.
    Baliga, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [3] Is COVID Vaccine Associated with Development of De Novo Donor Specific Antibodies in Lung Transplant Recipients?
    Nandavaram, S.
    Benninger, L.
    Scheuble, V.
    Chandrashekaran, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S158 - S159
  • [4] Role of rituximab for isolated de novo donor specific anti-HLA antibodies in renal transplant recipients
    Schafer, Antonia
    Ferrai-Lacraz, Sylvie
    Villard, Jean
    Hadaya, Karine
    SWISS MEDICAL WEEKLY, 2019, : 17S - 17S
  • [5] ROLE OF RITUXIMAB FOR ISOLATED DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Schafer, Antonia
    Hadaya, Karine
    Villard, Jean
    Ferrari-Lacrai, Sylvie
    HLA, 2020, 95 (04) : 322 - 322
  • [6] PERSISTENT DE NOVO DONOR-SPECIFIC ANTIBODIES ARE ASSOCIATED WITH DECREASED SURVIVAL IN LUNG TRANSPLANT RECIPIENTS
    Kauke, Teresa
    Schmitzer, Magdalena
    Kneidinger, Nikolaus
    Neurohr, Claus
    Schramm, Rene
    Von Dossow, Vera
    Winter, Hauke
    TRANSPLANT INTERNATIONAL, 2017, 30 : 33 - 33
  • [7] Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients.
    Parajuli, S.
    Alagusundaramoorthy, S.
    Aziz, F.
    Garg, N.
    Redfield, R.
    Sollinger, H.
    Kaufman, D.
    Djamali, A.
    Odorico, J.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 432 - 432
  • [8] Outcomes of Pancreas Transplant Recipients With De Novo Donor-specific Antibodies
    Parajuli, Sandesh
    Alagusundaramoorthy, Sayee
    Aziz, Fahad
    Garg, Neetika
    Redfield, Robert R.
    Sollinger, Hans
    Kaufman, Dixon
    Djamali, Arjang
    Odorico, Jon
    Mandelbrot, Didier
    TRANSPLANTATION, 2019, 103 (02) : 435 - 440
  • [9] Outcomes in Kidney Transplant Recipients That Develop De Novo Donor Specific Antibodies
    DeVos, J. M.
    Patel, S. J.
    Land, G.
    Knight, R. J.
    Achkar, K.
    Dilioglou, S.
    Dawson, K. L.
    Abdellatif, A.
    Gaber, A. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 294 - 294
  • [10] Incidence of De Novo Donor Specific Antibodies and Treatment Response for AMR in Pediatric Kidney Transplant Recipients
    Gattis, S.
    Liverman, R.
    Serluco, A.
    Yin, J.
    Sullivan, H. C.
    Bray, R. A.
    Gebel, H. M.
    Jernigan, S.
    George, R.
    Winterberg, P. D.
    Garro, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1065 - 1066
12345